Krystal Biotech, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €937.76M +15.1% €525.93M +30.8% 56.1% +0.067 pp N/A N/A
    (estimated) €814.64M +22.7% €401.94M +32.7% 49.3% +0.037 pp N/A N/A
    (estimated) €663.70M +36.2% €302.82M +45.0% 45.6% +0.028 pp N/A N/A
    (estimated) €487.34M +47.8% €208.84M +65.0% 42.9% +0.045 pp N/A N/A
    (estimated) €329.63M +31.7% €126.56M +64.8% 38.4% +0.077 pp N/A N/A
    €250.29M +473.0% €76.81M +715.6% 30.7% +0.091 pp €109.98M -265.8% 43.9% +2.0 pp
    €43.68M +∞% €9.42M -107.8% 21.6% +0.22 pp -€66.34M +61.8% -151.9% -1.5 pp
    €0.00 +NaN% -€120.60M +101.2% N/A -€41.00M -333.3% N/A
    €0.00 +NaN% -€59.94M +116.3% N/A €17.57M -281.5% N/A
    €0.00 +NaN% -€27.71M +68.5% N/A -€9.68M -8.7% N/A
    €0.00 -100.0% -€16.45M +75.3% N/A -€10.61M +70.8% N/A
    €884.81K +∞% -€9.38M +37.5% -1,060.3% -11 pp -€6.21M +96.0% -702.1% -7.0 pp
    €0.00 +NaN% -€6.82M +588.7% N/A -€3.17M +184.0% N/A
    €0.00 -€990.78K N/A -€1.12M N/A

    Notifications